What's New
6.11.09
"New Study Demonstrates NanoScan`s Novel Contrast Agent May Identify Heart Attack in Waiting" company press release
"New Study Demonstrates NanoScan`s Novel Contrast Agent May Identify Heart Attack in Waiting" company press release
Macrophages are the predominant cells involved in creating the progressive plaque lesions of atherosclerosis, a progressive disease and the main cause of cardiovascular disease - the number one killer worldwide. Atherosclerosis is caused by the build-up of plaques (fatty or fibrous deposits) in arterial walls. This can result in the narrowing of the arteries, which can reduce the supply of blood to vital organs such as the heart and brain. Plaques can also rupture, leading to a sudden, catastrophic blockage of blood flow. Plaques that are at high-risk or "vulnerable" to rupture are characterized by strong macrophage infiltration, which results in acute plaque destabilization and thrombus formation. The ability to examine, visualize, and differentiate vulnerable plaques in the arteries by obtaining detailed pictures using CT imaging with N1177 may help physicians identify high-risk but asymptomatic patients in new ways to treat a heart attack before it occurs. N1177 may also be of great value to drug developers seeking to examine changes in the size of plaque in response to therapeutic intervention, such as the use of cholesterol lowering statins.
NanoScan Imaging, LLC
2250 Berks Road
Lansdale, PA 19446
P: 610-647-3231
info@nanoscanimaging.com
www.nanoscanimaging.com